NASDAQ · Stocky rates: Avoid

CNP

$40.71 ▲ +0.10% as of 7 Aug, 19:00

Stocky turns companies like CNP into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
26
/ 100
Avoid

What Stocky thinks

Avoid. CNP scores poorly on both growth (24/100) and value (23/100) metrics, with a 20.9× forward P/E offering limited margin of safety. Leadership alignment is middling (53/100), and the company faces medium-severity structural risks from ERCOT and MISO directives in Texas and Indiana that constrain operational flexibility and earnings predictability.

Compounder Score
24/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
53/100
Founder-led, insider ownership, capital allocation history.
Vulnerability
17/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
23/100
Valuation vs peers and history — is this a good price to pay?

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for CNP:

26
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 26/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

53
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

17
RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

CNP (CNP) — frequently asked

Is CNP (CNP) a good investment right now?

Stocky rates CNP (CNP) at 26/100 — an Avoid — fundamentals or risks are too weak. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Avoid. CNP scores poorly on both growth (24/100) and value (23/100) metrics, with a 20.9× forward P/E offering limited margin of safety. Leadership alignment is middling (53/100), and the company faces medium-severity structural risks from

What is CNP's Stocky Verdict?

CNP's current Stocky Verdict is 26/100, placing it in the "Avoid" band. This composite combines a 24/100 Compounder score, 53/100 Leadership, Moat rating, and analyst signal.

Does CNP have a competitive moat?

Stocky hasn't finalised a Moat Score for CNP yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is CNP's leadership aligned with shareholders?

CNP scores 53/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to CNP?

CNP's Vulnerability Profile scores 17/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to CNP.

This is just the surface. See the whole picture on CNP.

Sign up free and unlock the full analysis on CNP — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering CNP — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for CNP.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how CNP changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to CNP?" · "Is CNP overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
26
/ 100 · Avoid

See CNP the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in CNP would be worth today.
Practice portfolio
Buy CNP with virtual money and track it — zero risk.
Free · no real money · learn by doing Open CNP in Stocky →

Or jump straight to the interactive dashboard for CNP in the app.